YOU ARE
A PATIENT
Access to your treatment of tomorrow
Access ToTem4meTHE BENEFICE FOR YOU
AS A PATIENT, CONNECT TO ToTem4me TO KEEP YOU INFORMED AND INVOLVED
01
Notifications: to remind you of their appointments and inform them if other clinical studies are available near them.
02
Mobile/tablet friendly
web application.
The progress of the research depends on your participation!
Clinical trials are a fundamental part of medical research that aims to find new ways to prevent, detect or treat diseases. These new treatments can be new molecules, combinations of different molecules, new ways of administering them, new treatment techniques (surgery, radiotherapy). The goal of clinical trials is to improve the treatment of patients at all stages of the disease. They allow us to evaluate the effectiveness and tolerance of new treatments before they are put on the market. When you participate in clinical research, you help doctors and researchers learn more about diseases and find alternative treatments for your disease.
Are you an IBD patient ? You are in the right place to find the right clinical trial for you
As an IBD patient, you have probably done a lot of research about your disease and its different stages, you have explored several websites and forums in search of answers, support or simply to exchange information. Telemedicine Technologies puts at your disposal the afa website that you can consult through the following link. afa is the only French association that supports and informs Crohn’s and ulcerative colitis patients and their relatives, defends their rights, and finances research.
Access ToTem4me
Current Research Studies
We understand the difficulties you are going through and the obstacles you face in finding clinical trials that are right for you. At Telemedicine Technologies, we support you and are actively working with physicians and patients (through the afa) to provide you with easy access to clinical trials near you so that you can find the innovative treatments you want and deserve. in a few clicks and minutes wherever you are! in total security!
Access ToTem4meHOW TO USE ToTem4me ?
On-line Patient Questionnaire
Connect to the ToTem4me application, fill out a questionnaire in 2 minutes, and find out if there are ongoing clinical trials in your area of choice that could potentially suit you.
Coordinator interview & study identification
The expert coordinator finetunes with you the identification of potential study(ies), explains clinical studies typical process, and confirms your interest.
Site
referral
The expert coordinator forwards your contact details to the hospital you select, so that an appointment is given to you. The investigational team confirms your potential eligibility and initiate the screening.
Patient
follow-up
The expert coordinator follows-up with the investigational team to ascertain that you had your appointment and enquires on the follow-up proposed.
HOW DOES ToTem4me PROTECT YOUR PRIVACY?
Your data is never shared with a trial site You have the right to be forgotten and have your data fully deleted. the coordinator has no access to your personnal datas Only limited information is captured to protect your privacy ToTem4me is GDPR compliant
Testimonials
« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress
« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »
LATEST NEWSOUR NEWS >
May 22, 2023
Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next to Mathieu Godart, CTO and co-founder of SÊMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]
May 22, 2023
Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agency’s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]
May 22, 2023
Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]